Hi 2020
Thanks for that reply,
It is still early days for Favipiravir imho, we have seen what is now happening with peramivir, when first it was hailed as the next great antiviral and now resistance seem to be a serious issue.
Only time will tell, but its good to keep a close eye on possible future contenders who could take market share away from Biota.
jojo
- Forums
- ASX - By Stock
- could favipirivir become a serious contender
Hi 2020Thanks for that reply,It is still early days for...
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online